Knight Therapeutics Inc KHTRF:OTCPK

*Data is delayed | Exchange | USD
Last | 03/26/24 EDT
4.02UNCH (UNCH)
52 week range
3.19 - 4.22
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close4.02
  • 52 Week High4.22
  • 52 Week High Date01/09/24
  • 52 Week Low3.19
  • 52 Week Low Date03/28/23

Key Stats

  • Market Cap392.33M
  • Shares Out101.17M
  • 10 Day Average Volume21,775.83
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change1.47

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close4.02
  • 52 Week High4.22
  • 52 Week High Date01/09/24
  • 52 Week Low3.19
  • 52 Week Low Date03/28/23
  • Market Cap392.33M
  • Shares Out101.17M
  • 10 Day Average Volume21,775.83
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change1.47

RATIOS/PROFITABILITY

  • EPS (TTM)-0.12
  • P/E (TTM)-32.66
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Knight Therapeutics Inc

 

Profile

MORE
Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invested in life sciences venture...
Jonathan Goodman
Executive Chairman of the Board
Samira Sakhia
President, Chief Executive Officer, Director
Arvind Utchanah
Chief Financial Officer
Jeff Martens
Global Vice President - Commercial
Address
3400 De Maisonneuve Blvd W
Montreal, QC
H3Z 3B8
Canada